These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

78 related articles for article (PubMed ID: 29845298)

  • 41. Loss of RUNX3 increases osteopontin expression and promotes cell migration in gastric cancer.
    Cheng HC; Liu YP; Shan YS; Huang CY; Lin FC; Lin LC; Lee L; Tsai CH; Hsiao M; Lu PJ
    Carcinogenesis; 2013 Nov; 34(11):2452-9. PubMed ID: 23774402
    [TBL] [Abstract][Full Text] [Related]  

  • 42. microRNA‑211 suppresses the growth and metastasis of cervical cancer by directly targeting ZEB1.
    Chen G; Huang P; Xie J; Li R
    Mol Med Rep; 2018 Jan; 17(1):1275-1282. PubMed ID: 29115509
    [TBL] [Abstract][Full Text] [Related]  

  • 43. MicroRNA-337 inhibits cell proliferation and invasion of cervical cancer through directly targeting specificity protein 1.
    Dong W; Li B; Wang J; Song Y; Zhang Z; Fu C
    Tumour Biol; 2017 Jun; 39(6):1010428317711323. PubMed ID: 28641487
    [TBL] [Abstract][Full Text] [Related]  

  • 44. MicroRNA‑34a attenuates the proliferation, invasion and metastasis of gastric cancer cells via downregulation of MET.
    Wei B; Huang QY; Huang SR; Mai W; Zhong XG
    Mol Med Rep; 2015 Oct; 12(4):5255-61. PubMed ID: 26238271
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The biological functions and mechanism of miR‑212 in prostate cancer proliferation, migration and invasion via targeting Engrailed-2.
    Zhou Y; Ji Z; Yan W; Zhou Z; Li H
    Oncol Rep; 2017 Sep; 38(3):1411-1419. PubMed ID: 28713997
    [TBL] [Abstract][Full Text] [Related]  

  • 46. miR-215 promotes malignant progression of gastric cancer by targeting RUNX1.
    Li N; Zhang QY; Zou JL; Li ZW; Tian TT; Dong B; Liu XJ; Ge S; Zhu Y; Gao J; Shen L
    Oncotarget; 2016 Jan; 7(4):4817-28. PubMed ID: 26716895
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Suppressive effects of microRNA-16 on the proliferation, invasion and metastasis of hepatocellular carcinoma cells.
    Wu WL; Wang WY; Yao WQ; Li GD
    Int J Mol Med; 2015 Dec; 36(6):1713-9. PubMed ID: 26499886
    [TBL] [Abstract][Full Text] [Related]  

  • 48. MicroRNA-106b regulates the tumor suppressor RUNX3 in laryngeal carcinoma cells.
    Xu Y; Wang K; Gao W; Zhang C; Huang F; Wen S; Wang B
    FEBS Lett; 2013 Oct; 587(19):3166-74. PubMed ID: 23912048
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Trichloroethylene-induced downregulation of miR-199b-5p contributes to SET-mediated apoptosis in hepatocytes.
    Ren X; Chen Z; Ruan J; Zhong J; Deng R; Liu W; Huang X; Yang X; Liu Y; Liu J
    Cell Biol Toxicol; 2019 Dec; 35(6):565-572. PubMed ID: 31140026
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The role of the tumor suppressor RUNX3 in giant cell tumor of the bone.
    Han YX; Liang DY
    Int J Oncol; 2012 Mar; 40(3):673-8. PubMed ID: 22076387
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Potential mechanisms of microRNA-129-5p in inhibiting cell processes including viability, proliferation, migration and invasiveness of glioblastoma cells U87 through targeting FNDC3B.
    Xu H; Hu Y; Qiu W
    Biomed Pharmacother; 2017 Mar; 87():405-411. PubMed ID: 28068630
    [TBL] [Abstract][Full Text] [Related]  

  • 52. MicroRNA-31 inhibits tumor invasion and metastasis by targeting RhoA in human gastric cancer.
    Ge F; Wang C; Wang W; Liu W; Wu B
    Oncol Rep; 2017 Aug; 38(2):1133-1139. PubMed ID: 28656284
    [TBL] [Abstract][Full Text] [Related]  

  • 53. miRNA-495 suppresses proliferation and migration of colorectal cancer cells by targeting FAM83D.
    Yan L; Yao J; Qiu J
    Biomed Pharmacother; 2017 Dec; 96():974-981. PubMed ID: 29221726
    [TBL] [Abstract][Full Text] [Related]  

  • 54. S100A4 mRNA as a prognostic marker and therapeutic target in Wilms tumor (WT).
    Li HJ; Chen YX; Wang Q; Zhang YG
    Eur Rev Med Pharmacol Sci; 2014; 18(6):817-27. PubMed ID: 24706305
    [TBL] [Abstract][Full Text] [Related]  

  • 55. LINC00173 promotes Wilms' tumor progression through MGAT1-mediated MUC3A
    Zhu Q; Zhan D; Yang Y; Chong Y; Xue H; Zhu P
    Cell Cycle; 2022 Sep; 21(17):1795-1810. PubMed ID: 35491865
    [TBL] [Abstract][Full Text] [Related]  

  • 56. MicroRNA‑190b expression predicts a good prognosis and attenuates the malignant progression of pancreatic cancer by targeting MEF2C and TCF4.
    Li Y; Wang Z; Zhao F; Zeng J; Yang X
    Oncol Rep; 2022 Jan; 47(1):. PubMed ID: 34779502
    [TBL] [Abstract][Full Text] [Related]  

  • 57. KIF11 as a potential cancer prognostic marker promotes tumorigenesis in children with Wilms tumor.
    Luo Y; Liu W; Zhu Y; Tian Y; Wu K; Ji L; Ding L; Zhang W; Gao T; Liu X; Zhao J
    Pediatr Hematol Oncol; 2022 Mar; 39(2):145-157. PubMed ID: 34378481
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Candidate genes and potential targets for therapeutics in Wilms' tumour.
    Blackmore C; Coppes MJ; Narendran A
    Clin Transl Oncol; 2010 Sep; 12(9):597-605. PubMed ID: 20851800
    [TBL] [Abstract][Full Text] [Related]  

  • 59. HOXB2 and FOXC1 synergistically drive the progression of Wilms tumor.
    Jing P; Zou J; Zhang L; Wang C; Yang Y; Deng L; Zhao D
    Exp Mol Pathol; 2020 Aug; 115():104469. PubMed ID: 32445751
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The roles of RUNX3 in cervical cancer cells
    Li Z; Fan P; Deng M; Zeng C
    Oncol Lett; 2018 Jun; 15(6):8729-8734. PubMed ID: 29805611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.